This means your bones aren't as strong or dense as they should be. Think of bone density like the thickness of a wall. Low bone density means the wall is thinner, making it more likely to break. It's often related to things like not getting enough calcium or vitamin D, or sometimes other health conditions.
Every report comes from a Lived member, sent anonymously.
Have you tried Fosamax (Alendronate) for Metabolic Bone Diseases?
Metabolic bone diseases are conditions in which the body's normal process of building, hardening and renewing bone goes wrong, leaving bones weaker or more likely to break. Bone is living tissue. Throughout life, old bone is broken down and replaced with new bone, and that balance depends on minerals such as calcium and phosphorus, on vitamin D and on hormones. When more bone is removed than replaced, or new bone does not harden properly, the skeleton loses strength. The most common form is low bone density. Osteoporosis is the more advanced stage, in which bones are fragile enough to break from a fall that would not normally cause harm, most often at the hip, spine or wrist. Low bone density that has not reached that point is called low bone mass or osteopenia. It has no symptoms of its own, but it raises the chance of developing osteoporosis and of breaking a bone. Both are usually silent: many people learn they have them only after a fracture or a bone density scan. The same umbrella term covers less common conditions that work differently. Osteomalacia (called rickets in children) means bones are soft because they do not mineralize properly, usually from a lack of vitamin D, and it tends to cause aching bone pain and muscle weakness. Overactive parathyroid glands can pull calcium out of bone, long-term kidney disease can upset the body's mineral balance, and Paget's disease of bone makes one or a few bones rebuild too quickly, so they become enlarged, softer and misshapen. Telling these apart matters because their treatments differ.
Age is the biggest factor in low bone density. Bone mass peaks in young adulthood, and bone is gradually lost after that. For women, the fall in estrogen after menopause speeds up that loss, which is one reason osteoporosis is more common in women. Being slim and small-boned, having a parent who had osteoporosis or broke a hip, and not building strong bones when young all add to risk. Other contributors can sometimes be changed: a diet low in calcium, vitamin D or protein, smoking, long-term heavy drinking, and long stretches of inactivity or bed rest. Some medicines affect bone when used for a long time, most notably corticosteroids (steroid medicines such as prednisone), and also some seizure medicines and proton pump inhibitors, which reduce stomach acid. Hormone disorders, rheumatoid arthritis, digestive diseases that interfere with absorption, chronic kidney or liver disease and eating disorders such as anorexia nervosa can all cause bone loss. When bone loss comes from another condition or a medicine, treating that cause is part of the plan. The rarer metabolic bone diseases have more specific causes. Osteomalacia usually comes from vitamin D deficiency, whether from little sun exposure, a diet low in vitamin D, or poor absorption after weight loss surgery or with bowel disease. Less often it stems from kidney or liver disease, certain seizure medicines or rare tumors that cause the body to lose phosphate. Paget's disease sometimes runs in families and is more common in older people of northern European heritage. Having risk factors raises the odds of bone disease but does not make it inevitable.
Low bone density and osteoporosis are diagnosed with a bone density scan called DXA (dual-energy X-ray absorptiometry), a quick X-ray test that usually measures the hip and lower spine. Screening is recommended for women 65 and older and men 70 and older. It is also advised from age 50 for postmenopausal women and men who have risk factors or who have broken a bone as an adult. The result is reported as a T-score, which compares your bone density with that of a healthy young adult. A T-score of -1.0 or higher is normal. A score between -1.0 and -2.5 means low bone mass (osteopenia). A score of -2.5 or lower means osteoporosis. So a T-score of -1.8 falls in the osteopenia range, while -2.7 meets the threshold for osteoporosis. Osteoporosis can also be diagnosed without that score when someone breaks a hip or a spine bone with little force. The T-score is not the whole picture. Most fractures actually happen in people whose scores are better than -2.5, because falls, frailty and bone quality matter too. Clinicians therefore estimate fracture risk with FRAX (the Fracture Risk Assessment Tool), which combines the scan result with age, prior fractures and other risk factors to give the chance of a hip fracture, and of any major osteoporosis-related fracture, over the next 10 years. Some people also need a spine X-ray or an extra image during the DXA to look for compression fractures in the spine, which often go unnoticed. Blood tests look for a cause. They usually check calcium, phosphate, vitamin D, kidney function, parathyroid hormone and alkaline phosphatase, an enzyme that rises when bone is being remodeled quickly. This matters because osteomalacia can look like osteoporosis on a bone density scan but needs different treatment. Paget's disease is almost always identified on X-rays, and a bone biopsy is occasionally needed when the cause of soft bones remains unclear.
Treatment depends on which bone disease is present and how likely a fracture is. For anyone with low bone density, the foundation is the same: enough calcium (about 1,000 mg a day for men 50 to 70 and 1,200 mg a day for women over 50 and men over 70, from food first, with supplements to fill a shortfall), enough vitamin D, adequate protein, regular weight-bearing and muscle-strengthening exercise, not smoking and limiting alcohol. Because most fractures follow a fall, preventing falls matters just as much. That can mean balance training, reviewing sedating medicines, updating glasses and removing hazards at home. Osteopenia does not automatically call for medication. US guidance suggests considering it when the FRAX estimate of a hip fracture over 10 years is 3% or higher, or the estimate of any major osteoporosis-related fracture is 20% or higher, or when someone with osteopenia has already broken a bone such as a wrist or upper arm. Many people with osteopenia are managed with the measures above and repeat scans. For osteoporosis, and for anyone who has broken a hip or spine bone, medication is usually recommended. The most widely used osteoporosis medicines are bisphosphonates, such as alendronate (Fosamax), which slow the cells that break down bone. In trials, alendronate cut spine and hip fractures by about half over three years in people with osteoporosis. Bisphosphonates come as weekly or monthly tablets, or as zoledronic acid, an infusion into a vein given once a year. Denosumab (Prolia) is an injection every six months that also slows bone breakdown. For people at very high risk, bone-building medicines such as teriparatide, abaloparatide or romosozumab are given as injections for a limited time and then followed by a drug like a bisphosphonate to hold on to the gains. Hormone therapy or raloxifene can be options for some women after menopause. These medicines have trade-offs. Bisphosphonate tablets can irritate the esophagus and must be taken in a specific way. Rarely, long-term use is linked to osteonecrosis of the jaw (a slow-healing area of jaw bone, usually after a tooth extraction) or an unusual fracture of the thigh bone, which is why dental work is planned with the prescriber and treatment is reviewed after several years. Denosumab should not be stopped without switching to another bone medicine, because bone loss rebounds quickly and multiple spine fractures can follow. People with advanced kidney disease need specialist input before starting some of these drugs. For people at high fracture risk, the chance of a fracture without treatment is usually much higher than the chance of these side effects. The other metabolic bone diseases are treated at their source. Osteomalacia is treated by replacing vitamin D, calcium and sometimes phosphorus, with larger doses for people who absorb nutrients poorly. Overactive parathyroid glands are often treated by surgically removing the overactive gland, particularly when bone density is already low or kidney stones have formed. Bone disease from kidney failure is managed with the kidney team, using a low-phosphorus diet, medicines called phosphate binders and forms of vitamin D. Paget's disease is most often treated with a bisphosphonate, which can reduce bone pain and slow the disease.
Low bone density and osteoporosis are long-term conditions, but they can be managed. Most people feel nothing from day to day, so the value of care is preventive: lowering the chance of a fracture that could affect mobility and independence. Treatment cannot promise that no bone will ever break, but even after a fracture, osteoporosis is treatable. Follow-up usually includes a repeat bone density scan one to two years after starting or changing medication, then at intervals based on risk. People with mild osteopenia and no fractures can often go longer between scans. Height is worth measuring each year, because gradual height loss can be a sign of spine fractures. People who have taken a bisphosphonate for several years (about five years of tablets or three years of yearly infusions) and are no longer at high risk may be offered a planned break with continued monitoring. Denosumab and the bone-building drugs are planned as a sequence with a follow-on medicine rather than simply stopped. A hip or spine fracture can bring pain, reduced mobility and a long recovery. The risk of another fracture is highest in the first one to two years after the first, which is why evaluation and treatment soon after a fracture matter, alongside physical therapy and fall prevention. The outlook for the less common forms varies. Osteomalacia from vitamin D deficiency often starts to improve within a few weeks of treatment, with bone healing generally within about six months, although it can return if the underlying cause persists. Paget's disease usually worsens slowly and does not spread to normal bones. Kidney-related bone disease tends to follow the course of the kidney condition.
Ask about a bone density check if you are a woman 65 or older or a man 70 or older, if you are over 50 with risk factors such as long-term steroid use, or if you have broken a bone as an adult in a fall from standing height or less. Any fracture from minor force is a reason to ask for a bone health evaluation, not only treatment of the break. Contact your care team if you notice you have lost height, have new back pain or a more stooped posture, since these can signal spine fractures. Also get in touch about widespread aching bone pain or muscle weakness, which can point to osteomalacia, or, if you take a bone medicine, new pain in the thigh or groin or a sore in the jaw that does not heal. Numbness or tingling around the mouth or in the hands and feet, or cramps and spasms in the hands or feet, can mean low calcium and call for prompt contact with your care team.
Last reviewed • Oct 2026
Educational content, not medical advice.
I have been diagnosed with osteopenia in the last two years. I am 57 years old and nearly 10 years post menopausal I’m trying to figure out what if any supplements I can take that will help my bone density. I find so many different answers on the Internet, and I am trying to figure out how many other people are going through the same thing I am.